Pancreatic Cancer
A Phase 2 Study of Futibatinib in Combination with PD-1 Antibody-based Standard of Care Therapy in Patients with Solid Tumors (TAS-120-206)
- Details
ClinicalTrials.gov ID:
NCT05945823
Diagnosis Type:
NA
USOR Number:
- Address
,
P: